Rocket Pharmaceuticals (RCKT) News Today $2.90 +0.02 (+0.56%) Closing price 07/3/2025 03:49 PM EasternExtended Trading$2.89 -0.01 (-0.21%) As of 07/3/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Rocket Pharmaceuticals Up Today?Toggle Visibility of Why Is Rocket Pharmaceuticals Up Today?Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares declined as multiple law firms announced or promoted securities class‐action lawsuits against the company, increasing legal risk and investor uncertainty. Neutral Sentiment: Rocket Fires Back At ‘Noise’ of Redfin Acquisition Being ‘Bad For Brokers’, an unrelated industry commentary that does not directly impact RCKT’s core biotech operations. Rocket Fires Back At ‘Noise’ of Redfin Acquisition Being ‘Bad For Brokers’ Negative Sentiment: ROSEN, SKILLED INVESTOR COUNSEL, encourages Rocket Pharmaceuticals investors to secure counsel before the August 11, 2025 deadline in a securities class action alleging misrepresentations. ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. ... Negative Sentiment: Rosen Law Firm reminds purchasers of RCKT shares between February 27, 2025 and May 26, 2025 to file for lead plaintiff by August 11, 2025 in a proposed class action. ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT Negative Sentiment: Morningstar reports investors who lost money on RCKT have an opportunity to lead a securities fraud lawsuit against the company. Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Negative Sentiment: Levi & Korsinsky notifies RCKT shareholders of a class action and August 11 deadline to join claims alleging false or misleading statements. Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT) Negative Sentiment: Bronstein, Gewirtz & Grossman LLC announces a class action for RCKT investors with substantial losses, targeting company officers for alleged securities fraud. RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Negative Sentiment: Robbins Geller Rudman & Dowd LLP alerts purchasers of RCKT securities of a class action and August 11 deadline to seek lead plaintiff status. RCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit Negative Sentiment: The Law Offices of Frank R. Cruz announce investors who lost money on RCKT may lead a securities fraud suit against the company. Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Negative Sentiment: Investors in Rocket Pharmaceuticals are urged by The Gross Law Firm to discuss their rights and potential lead plaintiff appointment before August 11. Investors in Rocket Pharmaceuticals, Inc. ... Negative Sentiment: The Gross Law Firm further issues a PR notice to RCKT shareholders outlining the August 11 deadline for lead plaintiff claims. Investors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT Negative Sentiment: Faruqi & Faruqi, LLP investigates claims on behalf of Rocket Pharmaceuticals investors, reminding them of the federal class action deadline. SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals Posted 14h agoAI Generated. May Contain Errors. RCKT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period US Air Force Suspends SpaceX Rocket Project on Pacific Atoll, Report SaysJuly 4 at 5:20 PM | usnews.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. ...July 4 at 12:34 PM | gurufocus.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKTJuly 4 at 11:17 AM | globenewswire.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MorningstarJuly 3 at 7:18 PM | morningstar.comMContact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)July 3 at 4:33 PM | globenewswire.comRCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 3 at 4:00 PM | globenewswire.comRCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitJuly 3 at 2:15 PM | prnewswire.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 3 at 12:37 PM | prnewswire.comInvestors in Rocket Pharmaceuticals, Inc. ...July 3 at 10:15 AM | gurufocus.comInvestors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKTJuly 3 at 9:00 AM | prnewswire.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket PharmaceuticalsJuly 3 at 8:01 AM | prnewswire.comRocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial – Hagens BermanJuly 2 at 6:05 PM | globenewswire.comRCKT LAWSUIT ALERT: The Gross Law Firm Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineJuly 2 at 4:15 PM | globenewswire.comRCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud LawsuitJuly 2 at 3:39 PM | prnewswire.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 2 at 12:00 PM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKTJuly 2 at 10:00 AM | prnewswire.comRocket completes purchase of real estate site RedfinJuly 2 at 8:22 AM | usatoday.comRocket Mortgage home equity loan review 2025July 2 at 8:22 AM | cnbc.comDeadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJuly 1, 2025 | globenewswire.comROSEN, A LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKTJuly 1, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKTJuly 1, 2025 | globenewswire.comInvestors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKTJuly 1, 2025 | prnewswire.comRocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial – Hagens BermanJune 30, 2025 | globenewswire.comROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Rocket Pharmaceuticals, Inc. Investors of Upcoming DeadlineJune 30, 2025 | globenewswire.comThe Gross Law Firm Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKTJune 30, 2025 | prnewswire.comThe Rocket Classic will have a new spot on the PGA Tour schedule in 2026June 30, 2025 | msn.comRocket Classic 2025 leaderboard: Final results and scores from Detroit Golf ClubJune 30, 2025 | msn.comAldrich Potgieter wins Rocket Classic after outlasting Max Greyserman, Chris KirkJune 29, 2025 | msn.comRocket Classic notes: Is DGC about to become a par 70 for the PGA Tour?June 29, 2025 | detroitnews.comD2025 Rocket Classic live updates: Max Greyserman, Aldrich Potgieter on fifth playoff holeJune 29, 2025 | msn.comAldrich Potgieter wins Rocket Classic on 5th playoff hole, outlasting Max Greyserman and Chris KirkJune 29, 2025 | msn.comAldrich Potgieter, 20, survives 'tough day,' emerges as Rocket champ in five-hole playoffJune 29, 2025 | detroitnews.comDRocket Classic 2025: Aldrich Potgieter survives wild three-man playoff to win in DetroitJune 29, 2025 | msn.comSovran Advisors LLC Purchases 172,324 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)June 29, 2025 | marketbeat.comRocket Lab launches 'Symphony of the Stars' missionJune 28, 2025 | msn.comWhat is the cut line at Rocket Classic? Who made and missed the cut?June 28, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKTJune 28, 2025 | globenewswire.comRCKT Investors Have the Opportunity to Lead the Rocket Pharmaceuticals Securities Fraud Lawsuit with Faruqi & Faruqi, LLPJune 28, 2025 | globenewswire.comRocket Classic notes: Yes, Detroit Golf Club is easy for these guys, but it's not outlierJune 28, 2025 | detroitnews.comDClass Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join – Contact The Gross Law Firm - MorningstarJune 28, 2025 | morningstar.comMTwo former Spartans fail to make the cut at the 2025 Rocket ClassicJune 28, 2025 | msn.comRocket Classic 2025: Third-round tee times, pairings at Detroit Golf ClubJune 28, 2025 | msn.comROSEN, LEADING INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKTJune 27, 2025 | prnewswire.comKnapp shoots 11-under 61 for Rocket Classic 18-hole record, marking 4th tournament record in 2 daysJune 27, 2025 | msn.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKTJune 27, 2025 | globenewswire.comLevi & Korsinsky Notifies Shareholders of Rocket Pharmaceuticals, Inc. (RCKT) of a Class Action Lawsuit and an Upcoming DeadlineJune 27, 2025 | globenewswire.comDeadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJune 27, 2025 | businesswire.comRocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial – Hagens BermanJune 27, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKTJune 27, 2025 | prnewswire.comRocket Pharmaceuticals, Inc. (RCKT) Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 11, 2025 to Discuss Your RightsJune 27, 2025 | globenewswire.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.000.54▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼389▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PAHC News Today BGM News Today ABCL News Today WVE News Today VERV News Today ELVN News Today NTLA News Today AKBA News Today COLL News Today ARDX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
